menu
    • menu

    Company profile for ProteinQure

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ProteinQure is a computational platform for protein drug discovery. We partner with pharma to deliver experimentally validated novel chemical matter. We combine molecular simulations, machine learning and high performance computing algorithms to perform structure-based drug design. These physics based methods make us less dependent on large data sets. We have 3 large commercial partnerships (see our partnering page).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ProteinQureCanada Flag
    Country
    Country
    Canada
    Address
    Address
    119 Spadina Ave Suite 304, Toronto, ON M5V 2L1
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.proteinqure.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/proteinqure/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/proteinqure?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ProteinQure Shows Brain Spread of Peptide-siRNA Conjugates
    ProteinQure Shows Brain Spread of Peptide-siRNA Conjugates

    15 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251015656420/en/ProteinQure-Reports-Broad-Brain-Distribution-of-Peptide-siRNA-Conjugates-in-Non-Human-Primates

    BUSINESSWIRE
    15 Oct 2025
    Share Share
    ProteinQure Doses 1st Patient in Ph I Trial of PQ203 for Cancer
    ProteinQure Doses 1st Patient in Ph I Trial of PQ203 for Cancer

    17 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250917696518/en/ProteinQure-Announces-First-Patient-Dosed-in-Phase-I-Clinical-Trial-of-PQ203-in-Advanced-Metastatic-Cancer

    BUSINESSWIRE
    17 Sep 2025
    Share Share
    ProteinQure Receives Clearance to Initiate Ph I Trial for PQ203
    ProteinQure Receives Clearance to Initiate Ph I Trial for PQ203

    07 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250807156682/en/ProteinQure-Receives-Regulatory-Clearance-to-Initiate-Phase-I-Trial-for-PQ203-in-the-U.S.-and-Canada-Granted-FDA-Fast-Track-Designation

    BUSINESSWIRE
    07 Aug 2025
    Share Share
    ProteinQure Raises Series A for AI Peptide Drug Trial
    ProteinQure Raises Series A for AI Peptide Drug Trial

    28 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250528843423/en/ProteinQure-Raises-Series-A-Financing-to-Advance-First-AI-Designed-Peptide-Therapeutic-into-Clinical-Trials

    BUSINESSWIRE
    28 May 2025
    Share Share
    ProteinQure Announces A Breakthrough Therapeutic of TNBC to be presented at AACR
    ProteinQure Announces A Breakthrough Therapeutic of TNBC to be presented at AACR

    25 Mar 2024

    // ACCESSWIRE

    https://www.accesswire.com/845508/proteinqure-announces-a-breakthrough-therapeutic-with-remarkable-efficacy-in-heterogenous-patient-derived-xenograft-models-of-triple-negative-breast-cancer-to-be-presented-at-aacr

    ACCESSWIRE
    25 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search